Persistent Asset Partners LTD Viridian Therapeutics, Inc.\De Transaction History

Persistent Asset Partners LTD

  • $121 Billion
  • Q4 2024

A detailed history of Persistent Asset Partners LTD transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Persistent Asset Partners LTD holds 25,237 shares of VRDN stock, worth $364,422. This represents 0.41% of its overall portfolio holdings.

Number of Shares
25,237
Holding current value
$364,422
% of portfolio
0.41%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$17.85 - $25.71 $450,480 - $648,843
25,237 New
25,237 $489 Million

About Viridian Therapeutics, Inc.\DE

VRDN Quotes by TradingView
  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $576M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Persistent Asset Partners LTD Portfolio

Follow Persistent Asset Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Persistent Asset Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Persistent Asset Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email